Patients using GLP-1 medications alongside insulin or sulfonylureas (e.g., glipizide, glimepiride, glyburide) face an increased risk of hypoglycemia
The absorptive rate depends on the exposure rate of glucose, region, and length of the small intestine, and the expression of glucose transporters (139)
As a result, clinicians must rely on clinical judgment and individual patient response
Patients combining coaching with GLP-1 pharmacotherapy often see 5 to 8% in the same timeframe, though individual variation is wide
supplied in a sterile, sealed vial for stability and consistency
At lower doses, this wearing-off effect hits harder and arrives earlier